Extended release, film-coated tablet of astemizole and pseudoephedrine
Patent 5681582 Issued on October 28, 1997. Estimated Expiration Date: 
November 8, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
November 8, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesProlonged release therapeutic compositions based on hydroxypropylmethylcellulose Cough/cold mixtures comprising non-sedating antihistamine drugs Cough/cold mixtures comprising non-sedating antihistamine drugs Pharmaceutical composition for piperidinoalkanol-decongestant combination Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination Patent #: 4999226 InventorsAssigneeApplicationNo. 545830 filed on 11/08/1995US Classes:424/468, Sustained or differential release type424/469, Discrete particles in supporting matrix424/470, Where particles are granulated424/472, Layered unitary dosage forms424/474, Coated pills or tablets424/476, Containing waxes, higher fatty acids, higher fatty alcohols, or derivatives thereof (e.g., chocolate)424/480Cellulose or derivativeExaminersPrimary: Krass, FrederickAttorney, Agent or FirmInternational ClassA61K 009/20Foreign Application Priority Data1993-06-14 EPAbstractThe present invention is concerned with an extended release, film coated tablet comprising as active ingredients the antihistaminic, antiallergic agent astemizole and the adrenergic, decongestant agent pseudoephedrine hydrochloride and with a process of preparing such tablets. | |
